dehaze, the Munich company building a foundational AI model for chronic disease detection, raised a €3.2M seed round co-led by YZR Capital and DN Capital, joined by Angel Invest, Zoho and Better Ventures. PHILIPPS & BYRNE performed the AI & Tech Due Diligence ahead of the round.
Read the full case study: Seeing Chronic Disease Earlier

.webp)


